破伤风类毒素载体蛋白在中老年成人接种后诱导T辅助细胞反应
研究纳入31名50-65岁中老年人,接种MenACWY-TT疫苗后,破伤风类毒素载体蛋白诱导了混合型Th1、Th2和Th17反应,且循环CD4+CXCR5+ICOS+IL21+细胞在接种后7天显著增加,但T细胞辅助与抗体反应无相关性。
要点
- 中老年人接种TT载体疫苗可诱导TT特异性Th1、Th2和Th17混合反应。
- 接种后7天循环CD4+CXCR5+ICOS+IL21+细胞显著增加。
- T细胞辅助与抗体反应无相关性,作者认为需进一步明确。
核心结论
- TT载体疫苗诱导的T细胞反应特征提示对脑膜炎球菌多糖可产生有效T细胞辅助,但与抗体反应无相关性需进一步明确。
- 中老年人在既往TT接种数十年后仍产生稳健T辅助细胞反应,支持将该年龄组纳入未来疫苗干预。
研究设计与样本
- 研究纳入31名50-65岁中老年人,接种MenACWY-TT疫苗,于接种前及接种后7天、28天、1年采集血样。
- 采用IFNγ Elispot和细胞培养上清中IFNγ、IL13、IL10、IL17、IL21分泌检测TT特异性T细胞反应,流式细胞术分析循环CD4+CXCR5+ICOS+IL21+细胞, bead-based免疫分析检测脑膜炎球菌和TT特异性IgG。
主要发现
- 接种TT载体蛋白在多数参与者中诱导混合TT特异性Th1(IFNγ)、Th2(IL13、IL10)和Th17(IL17)反应。
- 循环CD4+CXCR5+ICOS+IL21+细胞在接种后7天显著增加。
- 接种前TT特异性细胞因子产生和接种后Th2反应与CD4+CXCR5+ICOS+IL21+细胞增加正相关。
- T细胞辅助与抗体反应之间未发现相关性。
临床怎么用
- 原文未据此给出推荐。
局限性
- T细胞辅助与抗体反应无相关性需进一步明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Vaccines frequently induce suboptimal immune responses in the elderly, due to immunological ageing. Timely vaccination may be a strategy to overcome this problem, which classifies middle-aged adults asan interesting target group for future vaccine interventions. However, the immunological fitness of the middle-aged population is ill-defined. It is currently unknown whether effective T-cell help towards B-cells is initiated by conjugate-carrier vaccines at middle-age. AIM: We characterized systemic Tetanus Toxoid (TT) specific T-helper cell responses in the circulation of middle-aged adults (50-65years of age, n=31) having received the MenACWY-TT vaccination. METHODS: Blood samples were taken pre- as well as 7days, 28days, and 1year post-vaccination. TT-specific T-cell responses were determined by IFNγ Elispot and by the secretion of IFNγ, IL13, IL10, IL17, and IL21 in cell culture supernatants. Circulating CD4+CXCR5+ICOS+IL21+ cells were analyzed by flow cytometry, and meningococcal and TT-specific IgG responses by bead-based immunoassays. The correlation between the T-cell help and humoral responses was evaluated. RESULTS: Vaccination with a TT-carrier protein induced a mixed TT-specific Th1 (IFNγ), Th2 (IL13, IL10), and Th17 (IL17) response in most participants. Additionally, circulating CD4+CXCR5+ICOS+IL21+ cells were significantly increased 7days post-vaccination. Pre-vaccination TT-specific cytokine production and post-vaccination Th2 responses correlated positively with the increase of CD4+CXCR5+ICOS+IL21+ cells. No correlation between T-cell help and antibody responses was found. CONCLUSION: The characteristics of the T-cell response upon a TT-carrier vaccination suggests effective T-cell help towards B-cells in response to meningococcal polysaccharides, although the absence of a correlation with the antibody responses warrants further clarification. However, the robust T-helper cell response in middle-aged adults, decades after previous TT vaccinations, strengthens the classification of this age group for future vaccine interventions in the context of population ageing.
引用
- van der Heiden M, Duizendstra A, Berbers GAM, et al. Tetanus Toxoid carrier protein induced T-helper cell responses upon vaccination of middle-aged adults. Vaccine. 2017. PMID: 28882444. doi:10.1016/j.vaccine.2017.08.056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。